Table 3.
Positives stratified by age for Kato-Katz, qPCR and CCA, for each community: Tomefa, Torgahkope/Adakope and Manheam. For all test assays; n represents the total number of participants; Pos = number positive; and (Prev; 95% CI) = prevalence with 95% confidence interval
| Age | Kato-Katz | PCR | CCAa | CCAb | ||||
|---|---|---|---|---|---|---|---|---|
| n | Pos (Prev; 95% CI) | n | Pos (Prev; 95% CI) | n | Pos (Prev; 95% CI) | n | Pos (Prev; 95% CI) | |
| Tomefa | ||||||||
| 0–1 | 2 | 0 | 2 | 0 | 3 | 3 (100; 29.9–100) | 3 | 2 (66.7; 9.4–99.2) |
| 2–3 | 42 | 24 (57.1; 41–72.3) | 35 | 13 (37.1; 21.5–55.1) | 42 | 37 (88.1; 74.4–96) | 42 | 24 (57.1; 41–72.3) |
| 4–5 | 13 | 9 (69.2; 38.6–90.9) | 11 | 6 (54.5; 23.4–83.3) | 13 | 12 (92.3; 64–99.8) | 13 | 7 (53.8; 25.1–80.8) |
| Torgahkope/Adakope | ||||||||
| 0–1 | 1 | 0 | 1 | 0 | 1 | 1 (100; 2.5–100) | 1 | 0 |
| 2–3 | 37 | 6 (16.2; 6.2–32) | 28 | 5 (17.9; 6.1–36.9) | 37 | 32 (86.5; 71.2–95.5) | 37 | 6 (16.2; 6.2–32) |
| 4–5 | 19 | 2 (10.5; 1.3–33.1) | 14 | 2 (14.3; 1.8–42.8) | 19 | 17 (89.5; 66.9–98.7) | 19 | 2 (10.5; 1.3–33.1) |
| Manheam | ||||||||
| 0–1 | 3 | 0 | 3 | 1 (33.3; 0.8–90.6) | 3 | 3 (100; 29.2–100) | 3 | 2 (66.7; 9.4–99.2) |
| 2–3 | 34 | 2 (5.9; 0.7–19.7) | 32 | 3 (9.4; 2–25) | 34 | 28 (82.4; 65.5–93.2) | 34 | 6 (17.6; 6.8–34.5) |
| 4–5 | 24 | 2 (8.3; 1–27) | 22 | 4 (18.2; 5.2–40.3) | 25 | 19 (76; 54.9–90.6) | 25 | 7 (28; 12.1–49.4) |
aWith light/trace results
bWithout light/trace result